BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26354057)

  • 1. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.
    Lee CH; Lee J; Park YS; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Korean J Intern Med; 2015 Sep; 30(5):629-37. PubMed ID: 26354057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.
    Price DB; Baker CL; Zou KH; Higgins VS; Bailey JT; Pike JS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():551-61. PubMed ID: 24920893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.
    Tsiligianni IG; Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Schultz K; Kollen BJ; van der Molen T; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1045-52. PubMed ID: 27274226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients.
    Jo YS; Park S; Kim DK; Yoo CG; Lee CH
    BMC Pulm Med; 2018 Feb; 18(1):38. PubMed ID: 29482616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages.
    Karloh M; Fleig Mayer A; Maurici R; Pizzichini MMM; Jones PW; Pizzichini E
    Chest; 2016 Feb; 149(2):413-425. PubMed ID: 26513112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.
    Munari AB; Gulart AA; Dos Santos K; Venâncio RS; Karloh M; Mayer AF
    Respir Care; 2018 Jan; 63(1):77-85. PubMed ID: 28874609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.
    Jones PW; Adamek L; Nadeau G; Banik N
    Eur Respir J; 2013 Sep; 42(3):647-54. PubMed ID: 23258783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in classification of COPD patients into risk groups A-D: a cross-sectional study.
    Zogg S; Dürr S; Miedinger D; Steveling EH; Maier S; Leuppi JD
    BMC Res Notes; 2014 Aug; 7():562. PubMed ID: 25148698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.
    Miravitlles M; Koblizek V; Esquinas C; Milenkovic B; Barczyk A; Tkacova R; Somfay A; Zykov K; Tudoric N; Kostov K; Zbozinkova Z; Svoboda M; Sorli J; Krams A; Valipour A
    Respir Med; 2019 Apr; 150():141-148. PubMed ID: 30961941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.
    Moya-Álvarez V; Quevedo-Marín JL; Ji Z; Navarro-Jiménez C; Jiménez-García R; López-de-Andrés A; Pérez-Trullén A; de Miguel-Díez J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1987-1995. PubMed ID: 32848383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.